Journal retracts redundant case study of same patient from different authors

First paper version

Cureus has retracted a 2024 case study after learning it had published a piece about the identical patient, by authors from the same institution, just months earlier.  

The paper, “Lipoma Growing on the Back for 26 Years: A Bizarre Case Report,” was published March 26 and retracted June 17. Three of the four authors are affiliated with Datta Meghe Institute of Higher Education and Research, in Wardha, India. The corresponding author, Samiksha V. Gupta, was a medical student at the institution but has since received his degree. 

The notice states: 

Continue reading Journal retracts redundant case study of same patient from different authors

Journal investigating follow-up study that didn’t mention patients had died 

Peter Campbell

While presenting a paper in journal club, neurology resident at Baylor College of Medicine, Peter Campbell, noticed a potential problem. Two infants in a 2018 paper were reported to have died, but their data also appeared in a follow-up study published two years later with no mention of them being deceased. 

“It is unclear how a patient who reportedly died could be available for follow-up at 2 years,” he wrote in an email reporting his concerns to Frontiers, the publisher of the articles. The email, sent in April, went unanswered. 

Continue reading Journal investigating follow-up study that didn’t mention patients had died 

Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell

Nature has retracted a 2002 paper from the lab of Catherine Verfaillie purporting to show a type of adult stem cell could, under certain circumstances, “contribute to most, if not all, somatic cell types.” 

The retracted article, “Pluripotency of mesenchymal stem cells derived from adult marrow,” has been controversial since its publication. Still, it has been cited nearly 4,500 times, according to Clarivate’s Web of Science – making it by far the most-cited retracted paper ever.

In 2007, New Scientist reported on questions about data in the Nature paper and another of Verfaille’s articles in Blood. Nature published a correction that year. 

The errors the authors corrected “do not alter the conclusions of the Article,” they wrote in the notice. 

Continue reading Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell

Expression of concern coming for paper some used to link COVID-19 vaccines to deaths

The journal BMJ Public Health is placing an expression of concern on a paper it said “gave rise to widespread misreporting and misunderstanding,” namely, “claims that it implies a direct causal link between COVID-19 vaccination and mortality.” 

The article, “Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022,” appeared online June 3, and quickly attracted attention and criticism. The expression of concern is not yet live. 

In their conclusions, the authors wrote: 

Continue reading Expression of concern coming for paper some used to link COVID-19 vaccines to deaths

Climate paper retracted from Science over miscalculations

The authors of a paper published in Science have retracted their article following the discovery of calculation errors.

The article,“Drought sensitivity in mesic forests heightens their vulnerability to climate change” by Robert Heilmayr of the University of California, Santa Barbara and colleagues found that in drier areas, trees are less sensitive to drought and in hotter regions with a wet climate, tree growth is expected to decrease.

It has been cited once, according to Clarivate’s Web of Science. Since its publication in December, the article has been downloaded 4,641 times, posted by 154 X users, and written about by 20 news outlets and press release sites.

Continue reading Climate paper retracted from Science over miscalculations

Publisher slaps 60 papers in chemistry journal with expressions of concern

An Elsevier chemistry journal has marked more than 60 papers with expressions of concern amid an investigation involving potential undisclosed conflicts of interest among editors, authorship irregularities and manipulation of peer reviews and citations.

One of the notices, published online April 11 in Chemosphere, reads, for example:

Continue reading Publisher slaps 60 papers in chemistry journal with expressions of concern

Cureus retracts paper for plagiarism following Retraction Watch inquiries 

The journal Cureus has retracted a 2022 paper on cancer and the environment just weeks after Retraction Watch raised questions about apparent plagiarism in the article. 

As we reported in early April, the paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors”, had a bit of a twinsies thing going with a 2005 article in The Lancet – sharing a title, figures, and wording that “follows the Lancet one on a sentence-by-sentence level while using tortured phrases,” according to the anonymous tipster who informed us of the issue. 

The April 19 retraction notice states:

Continue reading Cureus retracts paper for plagiarism following Retraction Watch inquiries 

Send lawyers, Einstein and Maugham: Authors object to PLOS ONE retraction

Ming Zhou

Here’s a tale of a paper retracted because other articles published years later seemed to plagiarize it – and its unhappy authors, whose behavior the journal says hints at paper mill activity.

On January 16 of this year, Maria Zalm, a senior editor at PLOS ONE and team manager for publication ethics, asked the authors of a 2015 paper to respond to concerns about their work – which had been flagged on PubPeer the previous November – by February 6, according to an email seen by Retraction Watch. After some apparent back and forth, Zalm wrote to the authors on March 6 to say the journal had decided to retract the article.

Continue reading Send lawyers, Einstein and Maugham: Authors object to PLOS ONE retraction

Cureus reviewing paper alleged to plagiarize Lancet article

A 2022 paper in Cureus on causes of cancer around the world is under investigation by the journal following inquiries by Retraction Watch prompted by a reader’s email.

The paper, “Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioral and Environmental Risk Factors,” shares a title and figures with a 2005 paper in The Lancet. It also “follows the Lancet one on a sentence-by-sentence level while using tortured phrases,” an anonymous tipster told us.

As we’ve noted elsewhere in a report on the team that developed the phrase, “Tortured phrases are what happens to words that get translated from English into a foreign language, then back to English — perhaps by a computer trying to generate a scholarly publication for a group of unscrupulous authors.”

Continue reading Cureus reviewing paper alleged to plagiarize Lancet article

Exclusive: PLOS ONE to correct 1,000 papers, add author proof step

The megajournal PLOS ONE will be correcting about 1,000 papers over the next few months, Retraction Watch has learned, and will add an author proof step – a first for the journal.

The corrections are for “errors in author names, affiliations, titles and references; to make minor updates to the acknowledgements, funding statements, and data availability statements, among other minor issues,” PLOS ONE head of communications David Knutson told us. He continued:

This batch of corrections does not reflect a recent change in the journal’s quality control standards or processes. Rather, we are clearing a backlog that accumulated during a 2-year period when minor corrections were deprioritized and resources were diverted to other areas. PLOS ONE is in the process of implementing an author proof step so that in the future such errors can be identified and addressed prior to publication.  

Continue reading Exclusive: PLOS ONE to correct 1,000 papers, add author proof step